Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

Lamoureux, F., Baud'huin, M., Ory, B. et al. (5 more authors) (2014) Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma. Oncotarget, 5 (17). pp. 7805-7819. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. Copyright @ 2008-2016 Impact Journals, LLC. All rights reserved. Impact Journals is a trademark of Impact Journals, LLC .
Keywords: zoledronic acid; clusterin; osteosarcoma; bone tumor
Dates:
  • Published: 4 August 2014
  • Accepted: 3 August 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 13 Apr 2016 08:50
Last Modified: 13 Apr 2016 08:50
Published Version: http://dx.doi.org/10.18632/oncotarget.2308
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.2308
Related URLs:

Share / Export

Statistics